Research Progress on the Anticancer Effect of Ginsenoside Rh1

Area of Science:

• Natural Products Chemistry
• Oncology
• Pharmacology

Background:

• Cancer remains a leading cause of death globally, with conventional treatments facing challenges like side effects and drug resistance.
• Ginseng, a traditional Chinese medicine, contains active compounds with therapeutic potential.
• Ginsenoside Rh1 has emerged as a key compound with notable anticancer properties.

Purpose of the Study:

• To systematically review the anticancer effects and molecular mechanisms of Ginsenoside Rh1.
• To explore the potential of Ginsenoside Rh1 in various cancer types, including hepatocellular, gastric, colon, breast, ovarian, cervical, lung, and glioma.
• To provide a theoretical basis for developing novel anticancer drugs based on Ginsenoside Rh1.

Main Methods:

• Literature review of in vitro and animal studies on Ginsenoside Rh1.
• Analysis of molecular mechanisms, including signaling pathways, apoptosis, MMPs expression, angiogenesis, and immune microenvironment regulation.
• Evaluation of Ginsenoside Rh1's effects on cancer cell proliferation, migration, and invasion.

Main Results:

• Ginsenoside Rh1 demonstrates significant inhibition of proliferation, migration, and invasion in multiple cancer cell lines.
• Rh1 induces apoptosis and regulates key cancer-related pathways, MMPs expression, angiogenesis, and the immune microenvironment.
• Studies confirm Rh1's efficacy in vitro and in animal models, highlighting its broad-spectrum anticancer activity.

Conclusions:

• Ginsenoside Rh1 exhibits potent anticancer activities through diverse molecular mechanisms.
• Clinical translation requires further investigation into pharmacokinetics, safety, and precise targets.
• Rh1 holds promise for combination therapies and development of novel anticancer agents.